Heqi Bu
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Pharmacology top 10%
Papers in
-
- Bioactive Natural Diterpenoids Research 8
- Cell death mechanisms and regulation 7
- Extracellular vesicles in disease 2
- Epigenetics and DNA Methylation 2
-
- Autophagy in Disease and Therapy 5
- Co-authors
- Junhui Cui (5 shared papers)Zhaohong Wang (7 shared papers)Luo Jiang (4 shared papers)DIAN-LEI LIU (4 shared papers)Sheng‐Zhang Lin (4 shared papers)Hongfei Tong (3 shared papers)Hai Huang (2 shared papers)Feng Shen (3 shared papers)
- Journals
- Oncology Reports (4 papers)Phytomedicine (2 papers)OncoTargets and Therapy (2 papers)International Journal of Oncology (2 papers)Japanese Journal of Clinical Oncology (1 paper)
- Partner nations
- China
In The Last Decade
Heqi Bu
18 papers receiving 448 citations
Peers
Comparison fields: 5 of 66
- Toxicology 35
- Pharmacology 61
- Sensory Systems 30
- Cancer Research 72
- Molecular Biology 275
Countries citing papers authored by Heqi Bu
This map shows the geographic impact of Heqi Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heqi Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heqi Bu more than expected).
Fields of papers citing papers by Heqi Bu
This network shows the impact of papers produced by Heqi Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heqi Bu. The network helps show where Heqi Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Heqi Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 56 | |
| 2 | 2013 | 54 | |
| 3 | 2011 | 46 | |
| 4 | 2012 | 44 | |
| 5 | 2016 | 43 | |
| 6 | 2012 | 34 | |
| 7 | 2020 | 32 | |
| 8 | 2013 | 30 | |
| 9 | 2019 | 24 | |
| 10 | 2014 | 23 | |
| 11 | 2015 | 18 | |
| 12 | 2019 | 16 | |
| 13 | 2018 | 13 | |
| 14 | 2024 | 9 | |
| 15 | 2020 | 6 | |
| 16 | 2019 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2024 | 1 |
About Heqi Bu
Heqi Bu is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Oncology and Physiology, having authored 18 papers that have together received 453 indexed citations. Recurring topics across this work include Bioactive Natural Diterpenoids Research (8 papers), Cell death mechanisms and regulation (7 papers), Autophagy in Disease and Therapy (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Calcium signaling and nucleotide metabolism (2 papers), Extracellular vesicles in disease (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Toxicology (35 citations), Pharmacology (61 citations), Sensory Systems (30 citations), Cancer Research (72 citations) and Molecular Biology (275 citations). Heqi Bu has collaborated with scholars based in China. Frequent co-authors include Junhui Cui, Zhaohong Wang, Luo Jiang, DIAN-LEI LIU, Sheng‐Zhang Lin, Hongfei Tong, Hai Huang, Feng Shen, Jianhong Zhang and Ye Li. Their work appears in journals such as Oncology Reports, Phytomedicine, OncoTargets and Therapy, International Journal of Oncology and Japanese Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.